Cargando…

The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer

Background and Objectives: To date, sparse evidence exists about the impact of inflammatory serum markers in predicting perioperative complications after radical cystectomy (RC) for bladder cancer (BC). Here, we evaluated the role of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte r...

Descripción completa

Detalles Bibliográficos
Autores principales: Claps, Francesco, Rossin, Giulio, van Rhijn, Bas W. G., Mir, Maria Carmen, Mertens, Laura S., Ongaro, Luca, Traunero, Fabio, Iachimovsky, Alexandra I., Piasentin, Andrea, Vedovo, Francesca, Perotti, Alessandro, Tulone, Gabriele, Zucchi, Alessandro, Liguori, Giovanni, Simonato, Alchiede, Bartoletti, Riccardo, Trombetta, Carlo, Pavan, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220654/
https://www.ncbi.nlm.nih.gov/pubmed/37241158
http://dx.doi.org/10.3390/medicina59050926
_version_ 1785049269404696576
author Claps, Francesco
Rossin, Giulio
van Rhijn, Bas W. G.
Mir, Maria Carmen
Mertens, Laura S.
Ongaro, Luca
Traunero, Fabio
Iachimovsky, Alexandra I.
Piasentin, Andrea
Vedovo, Francesca
Perotti, Alessandro
Tulone, Gabriele
Zucchi, Alessandro
Liguori, Giovanni
Simonato, Alchiede
Bartoletti, Riccardo
Trombetta, Carlo
Pavan, Nicola
author_facet Claps, Francesco
Rossin, Giulio
van Rhijn, Bas W. G.
Mir, Maria Carmen
Mertens, Laura S.
Ongaro, Luca
Traunero, Fabio
Iachimovsky, Alexandra I.
Piasentin, Andrea
Vedovo, Francesca
Perotti, Alessandro
Tulone, Gabriele
Zucchi, Alessandro
Liguori, Giovanni
Simonato, Alchiede
Bartoletti, Riccardo
Trombetta, Carlo
Pavan, Nicola
author_sort Claps, Francesco
collection PubMed
description Background and Objectives: To date, sparse evidence exists about the impact of inflammatory serum markers in predicting perioperative complications after radical cystectomy (RC) for bladder cancer (BC). Here, we evaluated the role of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic immune-inflammation index (SII), C-reactive protein (CRP), and plasma fibrinogen in predicting perioperative morbidity and unplanned 30-days readmission after RC for BC. Materials and methods: We relied on a collaborative database of 271 patients who underwent open RC for cT1-4a N0 M0 BC between January 2012 and December 2022. Univariable and multivariable binomial logistic regression analyses were performed to assess the odds ratio (OR) with 95% confidence intervals (CI) testing the ability of each serum marker to predict postoperative complications (any-grade and major complications), and 30-days unplanned readmission. Results: The median age at RC was 73 yr (IQR 67–79). A total of 182 (67.2%) patients were male and the median BMI was 25.2 (IQR 23.2–28.4). Overall, 172 (63.5%) patients had a Charlson Comorbidity Index (CCI) greater than 2 points and 98 (36.2%) were current smokers at the time of RC. Overall, 233 (86.0%) patients experienced at least one complication after RC. Of these, 171 (63.1%) patients had minor complications (Clavien–Dindo grade 1–2) while 100 (36.9%) experienced major complications (Clavien–Dindo grade ≥ 3). According to multivariable analysis, current smoking status, high plasma fibrinogen, and preoperative anemia were independently associated with major complications (OR 2.10, 95%CI 1.15–4.90, p = 0.02), (OR 1.51, 95%CI 1.26–1.98, p = 0.09), and (OR 1.35, 95%CI 1.17–2.57, p = 0.03), respectively. Overall, 56 (20.7%) patients experienced a 30-days unplanned readmission. According to univariable analysis, high preoperative CRP and hyperfibrinogenemia were significantly associated with an increased risk of unplanned readmission (OR 2.15, 95%CI 1.15–4.16, p = 0.02; OR 2.18, 95%CI 1.13–4.44, p = 0.02, respectively). Conclusions: In our study, the preoperative immune-inflammation signature described by NLR, PLR, LMR, SII, and CRP showed a low reliability in predicting perioperative course after RC. Preoperative anemia and hyperfibrinogenemia were independent predictors of major complications. Further studies are pending in order to draw definitive conclusions.
format Online
Article
Text
id pubmed-10220654
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102206542023-05-28 The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer Claps, Francesco Rossin, Giulio van Rhijn, Bas W. G. Mir, Maria Carmen Mertens, Laura S. Ongaro, Luca Traunero, Fabio Iachimovsky, Alexandra I. Piasentin, Andrea Vedovo, Francesca Perotti, Alessandro Tulone, Gabriele Zucchi, Alessandro Liguori, Giovanni Simonato, Alchiede Bartoletti, Riccardo Trombetta, Carlo Pavan, Nicola Medicina (Kaunas) Article Background and Objectives: To date, sparse evidence exists about the impact of inflammatory serum markers in predicting perioperative complications after radical cystectomy (RC) for bladder cancer (BC). Here, we evaluated the role of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic immune-inflammation index (SII), C-reactive protein (CRP), and plasma fibrinogen in predicting perioperative morbidity and unplanned 30-days readmission after RC for BC. Materials and methods: We relied on a collaborative database of 271 patients who underwent open RC for cT1-4a N0 M0 BC between January 2012 and December 2022. Univariable and multivariable binomial logistic regression analyses were performed to assess the odds ratio (OR) with 95% confidence intervals (CI) testing the ability of each serum marker to predict postoperative complications (any-grade and major complications), and 30-days unplanned readmission. Results: The median age at RC was 73 yr (IQR 67–79). A total of 182 (67.2%) patients were male and the median BMI was 25.2 (IQR 23.2–28.4). Overall, 172 (63.5%) patients had a Charlson Comorbidity Index (CCI) greater than 2 points and 98 (36.2%) were current smokers at the time of RC. Overall, 233 (86.0%) patients experienced at least one complication after RC. Of these, 171 (63.1%) patients had minor complications (Clavien–Dindo grade 1–2) while 100 (36.9%) experienced major complications (Clavien–Dindo grade ≥ 3). According to multivariable analysis, current smoking status, high plasma fibrinogen, and preoperative anemia were independently associated with major complications (OR 2.10, 95%CI 1.15–4.90, p = 0.02), (OR 1.51, 95%CI 1.26–1.98, p = 0.09), and (OR 1.35, 95%CI 1.17–2.57, p = 0.03), respectively. Overall, 56 (20.7%) patients experienced a 30-days unplanned readmission. According to univariable analysis, high preoperative CRP and hyperfibrinogenemia were significantly associated with an increased risk of unplanned readmission (OR 2.15, 95%CI 1.15–4.16, p = 0.02; OR 2.18, 95%CI 1.13–4.44, p = 0.02, respectively). Conclusions: In our study, the preoperative immune-inflammation signature described by NLR, PLR, LMR, SII, and CRP showed a low reliability in predicting perioperative course after RC. Preoperative anemia and hyperfibrinogenemia were independent predictors of major complications. Further studies are pending in order to draw definitive conclusions. MDPI 2023-05-11 /pmc/articles/PMC10220654/ /pubmed/37241158 http://dx.doi.org/10.3390/medicina59050926 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Claps, Francesco
Rossin, Giulio
van Rhijn, Bas W. G.
Mir, Maria Carmen
Mertens, Laura S.
Ongaro, Luca
Traunero, Fabio
Iachimovsky, Alexandra I.
Piasentin, Andrea
Vedovo, Francesca
Perotti, Alessandro
Tulone, Gabriele
Zucchi, Alessandro
Liguori, Giovanni
Simonato, Alchiede
Bartoletti, Riccardo
Trombetta, Carlo
Pavan, Nicola
The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer
title The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer
title_full The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer
title_fullStr The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer
title_full_unstemmed The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer
title_short The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer
title_sort utility of inflammatory serum markers in the assessment of perioperative morbidity after radical cystectomy for bladder cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220654/
https://www.ncbi.nlm.nih.gov/pubmed/37241158
http://dx.doi.org/10.3390/medicina59050926
work_keys_str_mv AT clapsfrancesco theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT rossingiulio theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT vanrhijnbaswg theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT mirmariacarmen theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT mertenslauras theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT ongaroluca theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT traunerofabio theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT iachimovskyalexandrai theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT piasentinandrea theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT vedovofrancesca theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT perottialessandro theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT tulonegabriele theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT zucchialessandro theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT liguorigiovanni theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT simonatoalchiede theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT bartolettiriccardo theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT trombettacarlo theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT pavannicola theutilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT clapsfrancesco utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT rossingiulio utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT vanrhijnbaswg utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT mirmariacarmen utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT mertenslauras utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT ongaroluca utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT traunerofabio utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT iachimovskyalexandrai utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT piasentinandrea utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT vedovofrancesca utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT perottialessandro utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT tulonegabriele utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT zucchialessandro utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT liguorigiovanni utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT simonatoalchiede utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT bartolettiriccardo utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT trombettacarlo utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer
AT pavannicola utilityofinflammatoryserummarkersintheassessmentofperioperativemorbidityafterradicalcystectomyforbladdercancer